0 Commentaires
0 Parts
811 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Connectez-vous pour aimer, partager et commenter!
-
Experts Warn of Disease Gaps While Ivermectin Gains BuzzAs public health experts raise alarms over critical gaps in disease preparedness, Ivermectin has emerged at the center of national healthcare debates. With concerns about the CDC’s capacity to manage outbreaks, questions around public trust, and the balance between prevention and treatment, the drug has regained visibility in policy discussions and research priorities. The...0 Commentaires 0 Parts 14 Vue 0 Aperçu
-
Why Are American Patients Choosing Ivermectin Over Paxlovid in 2025?In 2025, the landscape of COVID-19 treatment options in the United States continues to evolve. While Paxlovid has been widely prescribed since its emergency authorization, a significant number of American patients are increasingly choosing Ivermectin for COVID-19 instead. This shift in preference is driven by various factors including perceptions of safety, cost considerations,...0 Commentaires 0 Parts 973 Vue 0 Aperçu